BioLife4D Corporation (SAVU)

BioLife4D was planning to go public, but the IPO was withdrawn on Feb 21, 2025.

IPO Price Range

$5.20 - $7.20

Shares Offered

1,596,154

Deal Size

$9.90M

BioLife4D Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Income	-2.25	-1.78	-1.59
Net Income	-1.96	-1.5	-1.7

Cash & Debt

Fiscal Year	Current	FY 2021	FY 2020
Period Ending	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Investments	0.44	0.93	0.33
Total Debt	1.02	0.75	0.9
Net Cash (Debt)	-0.58	0.19	-0.57
Net Cash Growth	-	-	-

Cash Flow & CapEx

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Cash Flow	-1.21	-1.12	-1.46
Capital Expenditures	-0.02	-	-0.01
Free Cash Flow	-1.22	-1.12	-1.47
Free Cash Flow Growth	-	-	-